Please assess the completion status of the following clinical trial:

Trial Title: Multi-Modal Anesthesia Protocol in Pain Management of Patients Undergoing Posterior Lumbar Spinal Fusion Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* lumbar stenosis affecting L1-S1~* Requiring Posterior Spinal Fusion Surgery~* Age 30-85 years~Exclusion Criteria:~* younger than 30 years old or older than 85 years~* Chronic Renal Disease~* Hypersensitivity to any medication~* history of chronic opioid abuse.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- MMA Protocol Group (Type: EXPERIMENTAL): Preoperative Medications~1. Orphenadrine 100mg PO once preop~2. Gabapentin 800mg PO once preop~3. Toradol 60mg IV once preop~4. Acetaminophen 1,000mg PO once preop~Intraoperative Paraspinal Infusion~1. Bupivacaine 30cc~2. Epinephrine 1cc~3. Xylocaine-MPF Intramuscular Inj 0.5% (30cc of Saline Solution)~Postoperative Medications~1. Orphenadrine 100mg PO BID~2. Gabapentin 300mg PO Q6~3. Toradol 30mg IV Q6hrs\*~4. Methylprednisolone 125mg Q8hrs
- Control (opioids) Group (Type: ACTIVE_COMPARATOR): Postoperative Medication~1-Morphine 4mg Q4hrs

Based on this trial design, predict the completion outcome and termination type (if applicable).